BiotechRudi Van den Eynde, Head of Thematic Global Equity and fund manager of Candriam Equities L Biotechnology at Candriam, answers investors’ questions about a sector where depth of specialist knowledge is a prerequisite to consistent stock selection success.

 

Download

EN | FR | NL | DE | IT | ES